Best-corrected visual acuity and frequency of ocular attacks during the initial 10 years in patients with Behçet's disease

Graefe's Archive for Clinical and Experimental Ophthalmology

Volumn 248, Issue 5, 2010, Pages 709-714

  Kaburaki, Toshikatsu ^a   Araki, Fumiyuki ^a   Takamoto, Mitsuko ^a   Okinaga, Kimiko ^b   Yoshida, Atsushi ^b   Numaga, Jiro ^a   Fujino, Yujiro ^a   Kawashima, Hidetoshi ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

Author keywords

Beh et's disease; Frequency; Long term observation; Ocular attack; Visual acuity

Indexed keywords

AZATHIOPRINE; COLCHICINE; CYCLOPHOSPHAMIDE; CYCLOSPORIN; INFLIXIMAB; PREDNISOLONE; TACROLIMUS;

ADULT; ARTICLE; BEHCET DISEASE; BEST CORRECTED VISUAL ACUITY; CATARACT; CHORIORETINOPATHY; CLINICAL ARTICLE; CONTROLLED STUDY; CONVALESCENCE; DISEASE COURSE; DISEASE DURATION; ENUCLEATION; EPIRETINAL MEMBRANE; EYE DISEASE; FEMALE; FOLLOW UP; FREQUENCY ANALYSIS; HUMAN; LONG TERM CARE; MALE; OCCLUDED PUPIL; ONSET AGE; OPTIC DISK ANOMALY; OPTIC DISK ATROPHY; PHTHYSIS; PRIORITY JOURNAL; PUPIL DISEASE; RETINA MACULA DEGENERATION; SECONDARY GLAUCOMA; TREATMENT DURATION; VISUAL ACUITY; VISUAL IMPAIRMENT; VITREORETINOPATHY;

ADULT; BEHCET SYNDROME; CHORIORETINITIS; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOSUPPRESSIVE AGENTS; IRITIS; MALE; OPTIC NEURITIS; RETINAL VASCULITIS; TIME FACTORS; UVEITIS; VISION DISORDERS; VISUAL ACUITY;

EID: 77952091452     PISSN: 0721832X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00417-009-1234-z     Document Type: Article

References (19)

1. Nakae K, Masaki F, Hashimoto F, Inaba G, Mochizuki M, Sakane T (1993) Recent epidemiological features of Behçet's disease in Japan. In: Godeau P, Wechsler B (eds) Behçet's disease. Excerpta Medica, Amsterdam, pp 145-151
2. Mochizuki M, Akduman L, Nussenblatt RB (1996) Behçet disease. In: Pepose JS, Holland GN, Wilhelmus KR (eds) Ocular infection and immunity. St. Louis, Mosby, pp 663-675
3. C Evereklioglu 2005 Current concepts in the etiology and treatment of Behçet disease Surv Ophthalmol 50 297 350 10.1016/j.survophthal.2005.04. 009 15967189 (Pubitemid 40828225)
4. S Ohno S Nakamura S Hori M Shimakawa H Kawashima M Mochizuki S Sugita S Ueno K Yoshizaki G Inaba 2004 Efficacy, safety, and pharmacokinetics of multiple administration of infliximab in Behçet's disease with refractory uveoretinitis J Rheumatol 31 1362 1368 1:CAS:528:DC%2BD2cXmtlSlt7o%3D 15229958
5. PP Sfikakis PG Theodossiadis CG Katsiari P Kaklamanis NN Markomichelakis 2001 Effect of infliximab on sight-threatening panuveitis in Behçet's disease Lancet 358 295 296 10.1016/S0140-6736(01)05497-6 1:CAS:528: DC%2BD3MXlslCjsLg%3D 11498218 (Pubitemid 32738970)
6. L Niccoli C Nannini M Benucci D Chindamo E Cassarà C Salvarani L Cimino G Gini I Lenzetti F Cantini 2007 Long-term efficacy of infliximab in refractory posterior uveitis of Behçet's disease: a 24-month follow-up study Rheumatology 46 1161 1164 10.1093/rheumatology/kem101 1:CAS:528: DC%2BD2sXosVSjtL0%3D 17478466 (Pubitemid 47050622)
7. S Mishima K Masuda Y Izawa M Mochizuki K Namba 1979 The eighth Frederick H. Verhoeff Lecture. Presented by Saiichi Mishima, MD. Behçet's disease in Japan: ophthalmologic aspects Trans Am Ophthalmol Soc 77 225 79 1:STN:280:DyaL3c7ptlSmsw%3D%3D 397657
8. JG Mamo 1970 The rate of visual loss in Behçet's disease Arch Ophthalmol 84 451 452 1:STN:280:DyaE3M%2FnvVGgtg%3D%3D 5492449
9. D Benezra E Cohen 1986 Treatment and visual prognosis in Behçet's disease Br J Ophthalmol 70 589 592 10.1136/bjo.70.8.589 1:STN:280: DyaL283ps1Grug%3D%3D 3741823
10. Y Mimura 1979 Immunopathological and clinical studies on ocular allergic diseases J Jpn Ophthalmol Soc 83 1909 1975 1:STN:280:DyaL3c7psFeqsQ%3D%3D
11. T Yuasa 1991 The etiology and clinical statistics of Behçet's disease Ganka (Jpn J Clin Ophthalmol) 33 225 232
12. M Miyake M Sunagawa S Okinami 1997 Behçet's disease characteristics more than 10 years after diagnosis Folia Ophthalmol Jpn 48 707 712
13. A Yoshida H Kawashima Y Motoyama H Shibui T Kaburaki K Shimizu K Ando K Hijikata Y Izawa K Hayashi J Numaga Y Fujino K Masuda M Araie 2004 Comparison of patients with Behçet's disease in the 1980s and 1990s Ophthalmology 111 810 815 10.1016/j.ophtha.2003.07.018 15051217 (Pubitemid 38429681)
14. M Takeuchi H Hokama R Tsukahara T Kezuka H Goto J Sakai M Usui 2005 Risk and prognostic factors of poor visual outcome in Behçet's disease with ocular involvement Graefe Arch Clin Exp Ophthalmol 243 1147 1152 10.1007/s00417-005-0005-8 (Pubitemid 43124166)
15. I Tugal-Tutkun S Onal R Altan-Yaycioglu H Huseyin Altunbas M Urgancioglu 2004 Uveitis in Behçet disease: an analysis of 880 patients Am J Ophthalmol 138 373 380 10.1016/j.ajo.2004.03.022 15364218 (Pubitemid 39208563)
16. RO Kaçmaz JH Kempen C Newcomb S Gangaputra E Daniel GA Levy-Clarke RB Nussenblatt JT Rosenbaum EB Suhler JE Thorne DA Jabs CS Foster Systemic Immunosuppressive Therapy for Eye Diseases Cohort Study Group 2008 Ocular inflammation in Behçet disease: incidence of ocular complications and of loss of visual acuity Am J Ophthalmol 146 828 836 10.1016/j.ajo.2008.06.019 18708181
17. Behçet's Disease Research Committee of Japan (1997) The Revised Criteria and Manual of Treatments of Behçet's disease. In: Report of Behçet Disease Research Comittee, Ministry of Health and Welfare of Japan, Tokyo, pp 22-29
18. MJ Hogan SJ Kimura P Thygeson 1959 Signs and symptoms of uveitis. I. Anterior uveitis Am J Ophthalmol 47 5, Part 2 155 170 1:STN:280: DyaG1M%2FnvFCksg%3D%3D 13649855
19. H Demiroǧlu I Barişta S Dündar 1997 Risk factor assessment and prognosis of eye involvement in Behçet's disease in Turkey Ophthalmology 104 701 705 9111266